InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-51.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by LAVIZZO-MOUREY RISA J, Director. Director active across 3 companies, notably INTEL CORP. In total, 16 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €508k. History available since 25 October 2021. The latest transaction was filed on 28 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
3,092 shares0Common Stock, par value $0.01 per shareSEC:0001628280-25-028703:0
2,440 shares0Common Stock, par value $0.01 per shareSEC:0001628280-24-024965:0
7,152 sharesCommon StockSEC:0001127602-24-014789:0
3,750 shares0Common StockSEC:0000950170-23-071960:0
3,584 shares0Common Stock, par value $0.01 per shareSEC:0001628280-23-019777:0
4,828 sharesCommon StockSEC:0001127602-23-015630:0
1,041 sharesCommon stock, par value $0.01 per shareSEC:0000899243-23-001119:0
3,720 sharesCommon StockSEC:0001127602-22-014677:0
1,993 sharesCommon StockSEC:0001127602-22-002837
1,993 sharesCommon StockSEC:0001127602-22-002837:0
10,000 shares@ US$4.60100.0% of flowCommon StockSEC:0000899243-21-049671
Ideal exit: 17 Sept 2022 (T+270)
10,000 shares@ US$4.6050.0% of flowCommon StockSEC:0000899243-21-049671:0
Ideal exit: 17 Sept 2022 (T+270)
5,000 shares@ US$49.500.0000% mcap50.0% of flowCommon StockSEC:0001127602-21-027641:0
Ideal exit: 22 Jul 2022 (T+270)
5,000 shares@ US$49.5050.0% of flowCommon StockSEC:0001127602-21-027641
Ideal exit: 22 Jul 2022 (T+270)
3,721 sharesCommon StockSEC:0001127602-21-017050:0
3,721 sharesCommon StockSEC:0001127602-21-017050
16 of 16 declarations
About LAVIZZO-MOUREY RISA J
Risa J. Lavizzo-Mourey is a Board Member of Intel Corp and Better Therapeutics, Inc. She plays a key role in the governance and strategy of these companies, contributing to their success.
